Page last updated: 2024-08-23

zidovudine and Disease Models, Animal

zidovudine has been researched along with Disease Models, Animal in 85 studies

Research

Studies (85)

TimeframeStudies, this research(%)All Research%
pre-19905 (5.88)18.7374
1990's39 (45.88)18.2507
2000's19 (22.35)29.6817
2010's18 (21.18)24.3611
2020's4 (4.71)2.80

Authors

AuthorsStudies
Hori, S; Kikkawa, T; Mori, S; Ohtsuki, S; Otagiri, M; Takanaga, H; Terasaki, T1
Allenspach, K; Asquith, CR; Hilton, ST; Hofmann-Lehmann, R; Konstantinova, LS; Laitinen, T; Meli, ML; Peräkylä, M; Poso, A; Rakitin, OA1
Allenspach, K; Asquith, CR; Hilton, ST; Hofmann-Lehmann, R; Konstantinova, LS; Laitinen, T; Meli, ML; Poso, A; Rakitin, OA1
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ1
Asquith, CRM; Coles, SJ; Hilton, ST; Hofmann-Lehmann, R; Laitinen, T; Poso, A; Sil, BC; Tizzard, GJ1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Borger, P; Buzdin, AA; Clavien, PA; Schneider, MA; Weber, A1
Jia, Y; Li, R; Liu, Y; Wang, Z; Xiao, X; Yang, K1
Ambati, J; Ambati, K; Ambati, M; Ambati, VL; Apicella, I; Baker, KL; Gelfand, BD; Marion, KM; Narendran, S; Pereira, F; Sadda, SR; Varshney, A; Wang, SB; Yerramothu, P1
Chen, Y; Liu, L; Liu, XD; Miao, MX; Sun, BB; Tang, XG; Wang, F; Wang, ZJ; Zhao, KJ1
Al-Khalidi, R; Ambati, J; Ambati, K; Arkle, S; Bruno, C; Chira, N; Cox, P; Gazzerro, E; Górecki, DC; McGeehan, RE; Panicucci, C; Róg, J; Young, CNJ; Zabłocki, K1
He, Y; Liu, X; Shu, J; Tang, SJ; Wu, T; Yang, Y; Zhang, W1
Chitolina Schetinger, MR; Dorneles Rodrigues, OE; Ineu, RP; Oliveira, VA; Pereira, ME; Saraiva, RA; Souza, D; Teixeira Rocha, JB; Thomé, GR1
Bissé, E; Iversen, L; Kirschner, J; Lebrecht, D; Reichard, W; Venhoff, AC; Venhoff, N; Walker, UA1
Chen, M; Girgis, S; Graham, D; Mason, AL; McDougall, C; Montano-Loza, A; Sharon, D; Sis, B; Wasilenko, ST; Zhang, G1
Andre-Schmutz, I; Blanche, S; Gibbons, AT; Poirier, MC; Rugeles, MT1
Armando, RG; Gomez, DE; Gomez, DM1
Hu, Y; Hua, Y; Huang, XY; Li, F; Luo, CX; Zhou, L; Zhou, QG; Zhu, DY1
Cai, HH; Chen, L; Ding, XS; Li, WL; Liu, N; Luo, CX; Wang, B; Zhou, QG; Zhu, DY1
Jena, GB; Pawar, AA; Ramarao, P; Tripathi, DN; Vikram, A1
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S1
Dugas, TR; Hebert, VY; Jiang, B; Khandelwal, AR; Stokes, KY1
Congote, LF; Difalco, MR; Dobocan, MC; Sadvakassova, G1
Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S1
Isajevs, S; Kalvinsh, I; Klusa, V; Pupure, J; Rumaks, J; Skapare, E; Svirina, D; Svirskis, S1
Afonso, PV; Bangham, CR; Dubreuil, G; Estaquier, J; Gessain, A; Hermine, O; Mahieux, R; Mekaouche, M; Moriceau, A; Mortreux, F; Plumelle, Y; Toulza, F; Wattel, E1
Cook, A; Divi, RL; Einem, TL; Fletcher, SL; Harbaugh, JW; Harbaugh, SW; Kuo, MM; Nagashima, K; Poirier, MC; Shockley, ME; St Claire, MC1
Espiridião, S; Kulay, L; Moreira de Carvalho, A; Pereira Fontes, TM; Restum Antonio, E; Simões, RS; Uchiyama Nakamurau, M1
Fields, E; Koczor, CA; Lewis, W; Ludaway, T; Park, J; Qin, Q; Russ, R; Torres, RA1
Bissé, E; Kirschner, J; Lebrecht, D; Pfeifer, D; Venhoff, AC; Venhoff, N; Walker, UA1
Campos, SB; de Araujo, M; Magaldi, AJ; Rienzo, M; Seguro, AC; Seguro, FS1
Chen, CL; Erbeck, D; Petkevich, AS; Uckun, FM; Vassilev, A; Venkatachalam, TK1
Cook, JE; Dasgupta, S; Gorry, PR; Middaugh, LD; Terry, EC; Tyor, WR; Wesselingh, SL1
Moyle, GJ1
Gordjushina, V; Isajevs, S; Kalvinsh, I; Klusa, V; Kratovska, A; Pupure, J; Rumaks, J; Svirskis, S; Taivans, I; Viksna, L1
de Jesus Simões, Ms; Kulay, L; Martins Oliveira, FH; Nakamura, MU; Oliveira-Filho, RM; Pereira Fontes, TM; Santos Simões, R1
Alder, J; Clement, J; Hui, YH1
Böttiger, D; Fleckenstein, B; Haseltine, WA; Hunsmann, G; Kaup, FJ; Li, J; Mätz-Rensing, K; Oberg, B; Stahl-Hennig, C; Uberla, K1
LaCasse, RA; North, TW1
Childers, TA; Ellis, MN; Johnson, CM; Selleseth, DW; Tompkins, MB; Tompkins, WA1
Marthas, ML; Van Rompay, K1
Bourut, C; Chenu, E; Mathé, G; Orbach-Arbouys, S1
Fish, DN1
Jaenisch, R; Sharpe, AH1
Pollack, S; Weaver, J1
Erickson, JG; Hayes, KA; Lafrado, LJ; Marr, JM; Mathes, LE1
Benveniste, O; Clayette, P; Dormont, D; Frétier, P; Le Grand, R; Le Naour, R; Noack, O; Théodoro, F; Vaslin, B1
Black, PL; McKinnon, KM; Ussery, MA; Wooden, SL1
Chen, C; Jiang, Y; Xu, H; Zhou, J; Zhu, G1
Chelstrom, LM; Dibirdik, I; Irvin, JD; Langlie, MC; Myers, DE; Tuel-Ahlgren, L; Uckun, FM1
Black, RJ1
Daniel, SS; Garland, M; Myers, MM; Stark, RI; Szeto, HH; Tropper, PJ1
Borgel, S; Elder, C; Flavin, MT; Hollingshead, MG; Khilevich, A; Xu, ZQ1
Bérard, E; Bongain, A; Gillet, JY; Monpoux, F1
Bailey, KW; Korba, BE; Morrey, JD; Sidwell, RW1
Amado, RG; Cole, SW; Cortado, R; Jamieson, BD; Zack, JA1
Gendelman, HE; Lanier, ER; Limoges, J; McClernon, DR; Persidsky, Y; Poluektova, L; Rasmussen, J; Ratanasuwan, W; Zelivyanskaya, M1
Giorgi, JV; Killian, S; Kitchen, SG; Zack, JA1
Bruggeman, L; Grupp, G; Grupp, IL; Hoit, B; Klotman, P; Lewis, W; Morris, R; Samarel, AM1
Korba, BE; Morrey, JD; Sidwell, RW1
Francke, S; Hayes, KA; Mathes, LE; Phipps, AJ1
Colin, JN; Desforges, B; Farinotti, R; Harcouet, L; Pocidalo, JJ; Sinet, M1
Joye, SM; Mandell, CP; Marthas, ML; McGowan, EK; Pedersen, NC; Ramos, RA; Van Rompay, KK1
Chow, FP; Hamburger, AW2
Kitamura, T; Komuro, K; Mizuochi, T; Ohnota, H; Okada, Y; Ushijima, H1
Basham, T; Holdener, T; Merigan, T1
Nixon, D1
Belardelli, F; Gresser, I; Locardi, C; Masuelli, L; Modesti, A; Petrini, C; Puddu, P; Sestili, P; Varano, F1
Alexander, F; Curtis, J; Doré, C; Harvey, JJ; Taylor-Robinson, D; Tuffrey, M; Wedderburn, N1
Basham, T; Herzenberg, LA; Merigan, TC; Portnoi, D; Schwartz, D; Stall, AM1
Kaneshima, H; McCune, JM; McGowan, J; Namikawa, R; Rabin, L; Sager, P; Shih, CC1
Baker, G; Levin, J; Roth, RI1
Jolicoeur, P1
Chen, IS; O'Brien, WA; Zack, JA1
Basham, T; Holdener, T; Merigan, TC; Rios, CD1
Burger, RA; Johnston, MI; Morrey, JD; Okleberry, KM; Sidwell, RW; Warren, RP1
Isono, T; Ogawa, K; Seto, A1
North, GL; North, TW; Pedersen, NC1
de Noronha, F; Postie, L; Roneker, C; Tavares, L1
Ruprecht, RM1
Newmark, P1
Gericke, D1

Reviews

9 review(s) available for zidovudine and Disease Models, Animal

ArticleYear
Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
    Current opinion in pediatrics, 2015, Volume: 27, Issue:2

    Topics: Aneuploidy; Animals; Animals, Newborn; Disease Models, Animal; DNA, Mitochondrial; Erythrocebus patas; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Zidovudine

2015
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
    HIV medicine, 2009, Volume: 10, Issue:7

    Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine

2009
Prophylaxis of HIV infection following occupational exposure.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:10

    Topics: Animals; Clinical Trials as Topic; Disease Models, Animal; Drug Costs; Health Personnel; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Occupational Diseases; Occupational Exposure; Risk Factors; Zidovudine

1993
Animal studies of prophylaxis.
    The American journal of medicine, 1997, May-19, Volume: 102, Issue:5B

    Topics: Adenine; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Administration Schedule; Interferon-alpha; Lentivirus Infections; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine

1997
[Antiretroviral therapy and prevention of maternal-fetal transmission of HIV-1. Current and future strategies].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:5

    Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Longitudinal Studies; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine

1999
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Antiviral therapy, 1998, Volume: 3, Issue:Suppl 3

    Topics: Administration, Oral; Animals; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B Virus, Woodchuck; Humans; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Polymerase Chain Reaction; Sex Factors; Time Factors; Viral Load; Virus Replication; Zidovudine

1998
Antiretroviral agents.
    IARC monographs on the evaluation of carcinogenic risks to humans, 2000, Volume: 76

    Topics: Acyclovir; Animals; Antiviral Agents; Carcinogens; Didanosine; Disease Models, Animal; Evidence-Based Medicine; Humans; Intestinal Absorption; Neoplasms; Risk Factors; Tissue Distribution; Zalcitabine; Zidovudine

2000
Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1991, Volume: 5, Issue:10

    Topics: Animals; Antineoplastic Agents; Concanavalin A; Cyclophosphamide; Cytokines; Disease Models, Animal; Mice; Murine Acquired Immunodeficiency Syndrome; Retroviridae; Virus Replication; Zidovudine

1991
Molecular pathogenesis of HIV-1.
    AIDS (London, England), 1990, Volume: 4 Suppl 1

    Topics: Animals; Disease Models, Animal; Genetic Variation; HIV Infections; HIV-1; Humans; Virus Replication; Zidovudine

1990

Other Studies

76 other study(ies) available for zidovudine and Disease Models, Animal

ArticleYear
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:3

    Topics: Animals; Biological Transport; Blood-Brain Barrier; Capillaries; Disease Models, Animal; Estrone; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Osteosclerosis; Penicillin G; RNA, Messenger

2004
Evaluation of the antiviral efficacy of bis[1,2]dithiolo[1,4]thiazines and bis[1,2]dithiolopyrrole derivatives against the nucelocapsid protein of the Feline Immunodeficiency Virus (FIV) as a model for HIV infection.
    Bioorganic & medicinal chemistry letters, 2014, Jun-15, Volume: 24, Issue:12

    Topics: Animals; Capsid Proteins; Cats; Cell Line; Cell Survival; Disease Models, Animal; HIV Infections; Humans; Immunodeficiency Virus, Feline; Molecular Structure; Pyrroles; Small Molecule Libraries; Thiazines

2014
Novel fused tetrathiocines as antivirals that target the nucleocapsid zinc finger containing protein of the feline immunodeficiency virus (FIV) as a model of HIV infection.
    Bioorganic & medicinal chemistry letters, 2015, Mar-15, Volume: 25, Issue:6

    Topics: Animals; Antiviral Agents; Benzamides; Binding Sites; Cats; Cell Line; Cell Survival; Disease Models, Animal; Immunodeficiency Virus, Feline; Molecular Docking Simulation; Nucleocapsid Proteins; Protein Binding; Protein Structure, Tertiary; Sulfhydryl Compounds; Zinc Fingers

2015
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection.
    Bioorganic & medicinal chemistry, 2019, 09-15, Volume: 27, Issue:18

    Topics: Animals; Cats; Disease Models, Animal; HIV Infections; Humans; Immunodeficiency Virus, Feline; Nucleocapsid Proteins; Piperazines

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer.
    Viruses, 2021, 11-30, Volume: 13, Issue:12

    Topics: Alkynes; Animals; Anti-Retroviral Agents; Antineoplastic Agents; Benzoxazines; Cell Proliferation; Colorectal Neoplasms; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Zidovudine

2021
Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coli.
    Communications biology, 2020, 04-03, Volume: 3, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Expression Regulation, Bacterial; Mice; Microbial Sensitivity Tests; Microbial Viability; Peritonitis; Tetracycline; Tetracycline Resistance; Zidovudine

2020
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.
    Investigative ophthalmology & visual science, 2020, 08-03, Volume: 61, Issue:10

    Topics: Animals; Blotting, Western; Caspase 1; Choroidal Neovascularization; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Geographic Atrophy; Interleukin-1beta; Intravitreal Injections; Macrophages; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Retinal Pigment Epithelium; Reverse Transcriptase Inhibitors; Zidovudine; Zonula Occludens-1 Protein

2020
Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp.
    Acta pharmacologica Sinica, 2017, Volume: 38, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Disease Models, Animal; Glucuronosyltransferase; Intestinal Absorption; Jejunum; Liver; Liver Failure, Acute; Male; Microsomes, Liver; Rats, Sprague-Dawley; Renal Elimination; Reverse Transcriptase Inhibitors; Thioacetamide; Zidovudine

2017
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Acta neuropathologica communications, 2018, 04-11, Volume: 6, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites; Calcium; Cells, Cultured; Collagen Type IV; Creatine Kinase; Disease Models, Animal; Male; Mice; Mice, Inbred mdx; Mice, Transgenic; Models, Molecular; Muscle Strength; Muscles; Muscular Dystrophy, Duchenne; Myoblasts; Receptors, Purinergic P2X7; Zidovudine

2018
Quercetin attenuates AZT-induced neuroinflammation in the CNS.
    Scientific reports, 2018, 04-18, Volume: 8, Issue:1

    Topics: Animals; Anti-HIV Agents; Antioxidants; Astrocytes; Central Nervous System Diseases; Cytokines; Disease Models, Animal; Mice; Quercetin; Wnt-5a Protein; Zidovudine

2018
Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
    Chemico-biological interactions, 2018, Oct-01, Volume: 294

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Binding Sites; Brain; Catalase; Catalytic Domain; Disease Models, Animal; Infusions, Intraventricular; Maze Learning; Memory; Mice; Molecular Docking Simulation; Neuroprotective Agents; Organoselenium Compounds; Oxidative Stress; Streptozocin; Zidovudine

2018
Zidovudine induces visceral mitochondrial toxicity and intra-abdominal fat gain in a rodent model of lipodystrophy.
    Antiviral therapy, 2014, Volume: 19, Issue:8

    Topics: Adipose Tissue; Adiposity; Animals; Anti-HIV Agents; Cyclooxygenase 1; Disease Models, Animal; DNA, Mitochondrial; Gene Dosage; Intra-Abdominal Fat; Lipodystrophy; Magnetic Resonance Imaging; Male; Mitochondria; Rats; Zidovudine

2014
Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:4

    Topics: Amino Acid Sequence; Animals; Anti-Retroviral Agents; Biomarkers; Cholangitis; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Lamivudine; Liver Cirrhosis, Biliary; Lopinavir; Mammary Tumor Virus, Mouse; Mice, Inbred NOD; Molecular Sequence Data; Protease Inhibitors; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Time Factors; Tumor Virus Infections; Viral Load; Zidovudine

2015
AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model.
    Oncology reports, 2016, Volume: 36, Issue:5

    Topics: Actin Cytoskeleton; Adenocarcinoma; Animals; Apoptosis; beta Catenin; Breast Neoplasms; Cell Division; Cell Movement; Cell Proliferation; Cyclin D1; Disease Models, Animal; Female; Humans; Proto-Oncogene Proteins c-myc; Telomerase; Telomere Homeostasis; Wnt Signaling Pathway; Zidovudine

2016
DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis.
    Psychopharmacology, 2008, Volume: 200, Issue:2

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Knockout; Neurogenesis; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroso Compounds; Stress, Psychological; Zidovudine

2008
Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke.
    Journal of neuroscience research, 2009, Volume: 87, Issue:1

    Topics: Analysis of Variance; Animals; Antimetabolites; Bromodeoxyuridine; Cell Count; Cognition Disorders; Disease Models, Animal; Fluoxetine; Infarction, Middle Cerebral Artery; Male; Maze Learning; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Space Perception; Swimming; Time Factors; Zidovudine

2009
Pre-bled-young-rats in genotoxicity testing: a model for peripheral blood micronucleus assay.
    Regulatory toxicology and pharmacology : RTP, 2008, Volume: 52, Issue:2

    Topics: Animals; Area Under Curve; Diethylnitrosamine; Disease Models, Animal; Hemorrhage; Male; Methotrexate; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Quercetin; Rats; Rats, Sprague-Dawley; Reticulocytes; Streptozocin; Time Factors; Zidovudine

2008
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
    AIDS (London, England), 2009, Feb-20, Volume: 23, Issue:4

    Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine

2009
HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model.
    Toxicology letters, 2009, Jun-22, Volume: 187, Issue:3

    Topics: Animals; Anti-HIV Agents; Atherosclerosis; Cholesterol; Disease Models, Animal; Glutathione; Glutathione Disulfide; Indinavir; Isoprostanes; Male; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Triglycerides; Tunica Intima; Zidovudine

2009
Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity.
    Journal of cellular physiology, 2009, Volume: 220, Issue:3

    Topics: Active Transport, Cell Nucleus; Anemia; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Fibroblasts; Glycophorins; Humans; Kidney; Leukemia, Erythroblastic, Acute; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Polypyrimidine Tract-Binding Protein; Protein Structure, Tertiary; Recombinant Proteins; RNA Interference; RNA-Binding Proteins; Skin; Thrombospondins; Time Factors; Transduction, Genetic; Zidovudine

2009
Neuroprotective properties of mildronate, a mitochondria-targeted small molecule.
    Neuroscience letters, 2010, Feb-12, Volume: 470, Issue:2

    Topics: Animals; Anti-HIV Agents; Brain; Caspase 3; Cellular Apoptosis Susceptibility Protein; Disease Models, Animal; Electron Transport Complex IV; Glial Fibrillary Acidic Protein; Lymphocytes; Male; Methylhydrazines; Mice; Mice, Inbred Strains; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide Synthase Type II; Zidovudine

2010
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.
    Blood, 2010, Nov-11, Volume: 116, Issue:19

    Topics: Animals; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD8-Positive T-Lymphocytes; Deltaretrovirus Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; HTLV-I Infections; Humans; Male; Monkey Diseases; Papio; Paraparesis, Tropical Spastic; Reverse Transcriptase Inhibitors; Simian T-lymphotropic virus 1; T-Lymphocyte Subsets; Valproic Acid; Viral Load; Zidovudine

2010
Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:1

    Topics: Animals; Animals, Newborn; Cerebral Cortex; Didanosine; Disease Models, Animal; DNA, Mitochondrial; Drug Therapy, Combination; Erythrocebus patas; Female; Lamivudine; Maternal Exposure; Mitochondria, Liver; Oxidative Phosphorylation; Pregnancy; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine

2010
Effects of daily intake of zidovudine-stavudine on rat pregnancy outcome: biological essay.
    Clinical and experimental obstetrics & gynecology, 2012, Volume: 39, Issue:2

    Topics: Animals; Anti-HIV Agents; Biological Assay; Disease Models, Animal; Drug Combinations; Female; HIV Infections; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rats; Stavudine; Weight Gain; Zidovudine

2012
Transgenic mouse model with deficient mitochondrial polymerase exhibits reduced state IV respiration and enhanced cardiac fibrosis.
    Laboratory investigation; a journal of technical methods and pathology, 2013, Volume: 93, Issue:2

    Topics: Analysis of Variance; Animals; Crosses, Genetic; Disease Models, Animal; DNA Polymerase gamma; DNA Primers; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Echocardiography; Endomyocardial Fibrosis; Genotype; Histological Techniques; Hydroxyproline; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondrial Diseases; Mutation, Missense; Myocardial Contraction; Oximetry; Respiratory Physiological Phenomena; Zidovudine

2013
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy.
    Arthritis research & therapy, 2012, Oct-29, Volume: 14, Issue:5

    Topics: Animals; Cell Transdifferentiation; Disease Models, Animal; Electron Transport; Male; Mitochondria, Muscle; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Muscular Atrophy; Muscular Diseases; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Zidovudine

2012
Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats.
    Clinical nephrology, 2003, Volume: 59, Issue:4

    Topics: Acute Kidney Injury; Animals; Anti-HIV Agents; Didanosine; Diet; Disease Models, Animal; HIV Infections; Hypokalemia; Magnesium; Male; Rats; Rats, Wistar; Risk Factors; Zidovudine

2003
Zidampidine, an aryl phosphate derivative of AZT: in vivo pharmacokinetics, metabolism, toxicity, and anti-viral efficacy against hemorrhagic fever caused by Lassa virus.
    Bioorganic & medicinal chemistry, 2005, May-02, Volume: 13, Issue:9

    Topics: Animals; Dideoxynucleotides; Disease Models, Animal; Female; Hydrolysis; Lassa Fever; Lassa virus; Mice; Mice, Inbred ICR; Molecular Structure; Thymine Nucleotides; Time Factors; Zidovudine

2005
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
    Annals of neurology, 2005, Volume: 57, Issue:6

    Topics: AIDS Dementia Complex; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Disease Models, Animal; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mice; Mice, SCID; Monocytes; Viral Load; Zidovudine

2005
The role of zidovudine in development of lipoatrophy.
    The AIDS reader, 2005, Volume: 15, Issue:11

    Topics: Adipose Tissue; Animals; Anti-HIV Agents; Disease Models, Animal; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Mice; Randomized Controlled Trials as Topic; Rats; Reverse Transcriptase Inhibitors; Zidovudine

2005
Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 99, Issue:4

    Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Heart Diseases; Methylhydrazines; Mice; Mice, Inbred ICR; Mitochondria; Zidovudine

2006
Extended administration of the association of zidovudine plus ritonavir during rat pregnancy: maternal and fetal effects.
    Clinical and experimental obstetrics & gynecology, 2007, Volume: 34, Issue:3

    Topics: Animals; Anti-HIV Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fetal Development; Fetal Growth Retardation; Fetal Resorption; Pregnancy; Random Allocation; Rats; Rats, Wistar; Ritonavir; Weight Gain; Zidovudine

2007
Efficacy of AZT therapy in reducing p24 antigen burden in a modified SCID mouse model of HIV infection.
    Antiviral research, 1995, Volume: 27, Issue:1-2

    Topics: Animals; Cell Line; Disease Models, Animal; Female; HIV Core Protein p24; HIV Infections; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Spleen; Time Factors; Zidovudine

1995
Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Aug-29, Volume: 92, Issue:18

    Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Animals; Antiviral Agents; Base Sequence; Cell Line; Disease Models, Animal; DNA Primers; HIV Reverse Transcriptase; HIV-1; Macaca fascicularis; Macaca mulatta; Molecular Sequence Data; Pyridines; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Zidovudine

1995
Testing anti-HIV drugs in the FIV model.
    Nature medicine, 1995, Volume: 1, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Animals; Cats; Disease Models, Animal; DNA, Viral; Drug Evaluation, Preclinical; Feline Acquired Immunodeficiency Syndrome; HIV Infections; HIV-1; Humans; Immunodeficiency Virus, Feline; Mutation; Zidovudine

1995
Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Veterinary immunology and immunopathology, 1995, Volume: 46, Issue:1-2

    Topics: Animals; Antibodies, Viral; Base Sequence; Cats; Chimera; Disease Models, Animal; DNA Primers; DNA, Viral; Feline Acquired Immunodeficiency Syndrome; Female; Immunodeficiency Virus, Feline; Immunoglobulin G; Lymphoid Tissue; Mice; Mice, SCID; Molecular Sequence Data; Polymerase Chain Reaction; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fes; Proto-Oncogenes; Proviruses; Severe Combined Immunodeficiency; Specific Pathogen-Free Organisms; Zidovudine

1995
"The Duesberg phenomenon": what does it mean?
    Science (New York, N.Y.), 1995, Jan-13, Volume: 267, Issue:5195

    Topics: Acquired Immunodeficiency Syndrome; Animals; Animals, Newborn; Disease Models, Animal; Humans; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine

1995
The in vivo effect of ellipticine analogues on the blood concentration of Friend virus: a murine model for studying anti-HIV drugs.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1993, Volume: 47, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Animals; Blood; Disease Models, Animal; Ellipticines; Friend murine leukemia virus; HIV Infections; HIV-1; Male; Mice; Mice, Inbred DBA; Zidovudine

1993
Retroviral spongiform degenerative disease produced by the murine neurotropic retrovirus Cas-Br-E.
    Developments in biological standardization, 1993, Volume: 80

    Topics: Animals; Animals, Wild; Central Nervous System; Disease Models, Animal; Female; Fetal Diseases; Gammaretrovirus; Gestational Age; In Situ Hybridization; Mice; Microinjections; Motor Neuron Disease; Pregnancy; Retroviridae Infections; Rodent Diseases; Zidovudine

1993
Azidothymidine (AZT)-induced siderosis.
    American journal of hematology, 1993, Volume: 43, Issue:3

    Topics: Animals; Disease Models, Animal; Heme; HIV Infections; Iron; Liver; Macrophages; Mice; Mice, Inbred Strains; Siderosis; Zidovudine

1993
Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.
    Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:2

    Topics: Age Factors; Aging; Animals; Antibodies, Viral; Antigens, Viral; Blotting, Southern; Cats; CD4-CD8 Ratio; Disease Models, Animal; Electrophoresis, Agar Gel; Feline Acquired Immunodeficiency Syndrome; Immunodeficiency Virus, Feline; Immunophenotyping; Infusions, Parenteral; Leukocyte Count; Lymphocytes; Polymerase Chain Reaction; Specific Pathogen-Free Organisms; Viremia; Zidovudine

1993
Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection.
    Journal of medical primatology, 1995, Volume: 24, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Biomarkers; Disease Models, Animal; Female; HIV; Humans; Macaca fascicularis; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tumor Necrosis Factor-alpha; Viremia; Virus Replication; Zidovudine

1995
Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
    International journal of immunopharmacology, 1996, Volume: 18, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Acridines; Animals; Antibodies; Antiviral Agents; Asialoglycoproteins; Disease Models, Animal; Drug Synergism; Female; G(M1) Ganglioside; Glucans; Guanosine; Immunologic Factors; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Poly I-C; Poly U; Pyran Copolymer; Rabbits; Rauscher Virus; Specific Pathogen-Free Organisms; Viral Plaque Assay; Zidovudine

1996
Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
    Biological trace element research, 1997,Winter, Volume: 59, Issue:1-3

    Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Female; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Selenium; Spleen; Splenomegaly; Superoxide Dismutase; Zidovudine; Zinc

1997
TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Disease Models, Animal; HIV-1; Humans; Immunoconjugates; Macaca fascicularis; Mice; Mice, SCID; N-Glycosyl Hydrolases; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Stavudine; Zidovudine

1998
Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Dec-15, Volume: 19, Issue:5

    Topics: Administration, Oral; Amniotic Fluid; Animals; Anti-HIV Agents; Area Under Curve; Disease Models, Animal; Female; Fetal Blood; Fetus; Half-Life; HIV Infections; Infectious Disease Transmission, Vertical; Papio; Pregnancy; Pregnancy, Animal; Zidovudine

1998
In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.
    Bioorganic & medicinal chemistry letters, 1999, Jan-18, Volume: 9, Issue:2

    Topics: Animals; Anti-HIV Agents; Cell Line; Cell Survival; Cells, Cultured; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Core Protein p24; HIV Reverse Transcriptase; Humans; Macrophages; Mice; Pyranocoumarins; Time Factors; Zidovudine

1999
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine.
    Antiviral research, 1999, Volume: 42, Issue:2

    Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis, Viral, Animal; Humans; Lamivudine; Male; Mice; Mice, Transgenic; Time Factors; Treatment Outcome; Virus Replication; Zidovudine

1999
Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
    Journal of virology, 1999, Volume: 73, Issue:8

    Topics: Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Models, Animal; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Kinetics; Lymphocyte Depletion; Mice; Mice, SCID; Reverse Transcriptase Inhibitors; Thymus Gland; Zidovudine

1999
Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice.
    Neurology, 2000, Jan-25, Volume: 54, Issue:2

    Topics: AIDS Dementia Complex; Animals; Cells, Cultured; Didanosine; Dideoxynucleosides; Disease Models, Animal; HIV-1; Humans; Lamivudine; Male; Mice; Mice, SCID; Monocytes; Reverse Transcriptase Inhibitors; Stavudine; Virus Replication; Zidovudine

2000
Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.
    Journal of virology, 2000, Volume: 74, Issue:6

    Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Models, Animal; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Mice; Mice, SCID; Receptors, Antigen, T-Cell, alpha-beta; Reverse Transcriptase Inhibitors; Thymus Gland; Zidovudine

2000
Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.
    Laboratory investigation; a journal of technical methods and pathology, 2000, Volume: 80, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Cardiomyopathies; Disease Models, Animal; HIV-1; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors; Ultrasonography; Zidovudine

2000
HE2000 shows efficacy.
    AIDS patient care and STDs, 1999, Volume: 13, Issue:6

    Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Drugs, Investigational; Haplorhini; Lamivudine; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Survival Analysis; Viral Load; Zidovudine

1999
Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:9

    Topics: Animals; Anti-HIV Agents; Cats; Disease Models, Animal; Feline Acquired Immunodeficiency Syndrome; HIV Infections; Immunodeficiency Virus, Feline; Lymphocyte Count; Lymphocytes; Phenotype; Plasma; Thymus Gland; Viral Load; Zidovudine

2000
Efficacy of continuous zidovudine infusion at early stages of retroviral infection in mice.
    Journal of acquired immune deficiency syndromes, 1992, Volume: 5, Issue:6

    Topics: Animals; Disease Models, Animal; Friend murine leukemia virus; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Retroviridae Infections; Virus Replication; Zidovudine

1992
Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Administration, Oral; Animals; Animals, Suckling; Disease Models, Animal; Injections, Intravenous; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Zidovudine

1992
Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
    Experimental hematology, 1992, Volume: 20, Issue:2

    Topics: Administration, Oral; Animals; Bone Marrow; Bone Marrow Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Erythropoiesis; Female; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Spleen; Time Factors; Zidovudine

1992
3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Animals; Disease Models, Animal; Drug Screening Assays, Antitumor; Immunoglobulin G; Leukemia, Experimental; Male; Mice; Mice, Inbred C57BL; Phytohemagglutinins; Reverse Transcriptase Inhibitors; Spleen; Tumor Virus Infections; Zidovudine

1990
Intermittent, alternating, and concurrent regimens of zidovudine and 2'-3' dideoxycytidine in the LP-BM5 murine induced immunodeficiency model.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:4

    Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Therapy, Combination; Female; HIV Infections; Mice; Mice, Inbred C57BL; Zalcitabine; Zidovudine

1991
Zidovudine after occupational exposure to HIV.
    BMJ (Clinical research ed.), 1991, Jul-27, Volume: 303, Issue:6796

    Topics: Animals; Disease Models, Animal; HIV Infections; Humans; Mice; Occupational Diseases; Occupational Exposure; Zidovudine

1991
In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS.
    European journal of haematology, 1991, Volume: 47, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Bone Marrow; Disease Models, Animal; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Erythropoiesis; Erythropoietin; Female; Hematocrit; Mice; Mice, Inbred C57BL; Pregnancy; Reticulocytes; Time Factors; Zidovudine

1991
Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
    Journal of virology, 1991, Volume: 65, Issue:5

    Topics: Animals; Antibodies; Cell Division; Disease Models, Animal; Female; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Immunosuppression Therapy; Interferon Type I; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Core Proteins; Virus Replication; Zidovudine

1991
Inhibition of urethane leukaemia virus, a murine retrovirus, in mice by zidovudine.
    International journal of STD & AIDS, 1990, Volume: 1, Issue:5

    Topics: Analysis of Variance; Animals; Cell Line; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Inbred BALB C; Organ Size; Retroviridae; Spleen; Splenomegaly; Viral Plaque Assay; Zidovudine

1990
Zidovudine (azido dideoxythymidine) inhibits characteristic early alterations of lymphoid cell populations in retrovirus-induced murine AIDS.
    Journal of immunology (Baltimore, Md. : 1950), 1990, Mar-01, Volume: 144, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antigens, Differentiation; Antigens, Ly; B-Lymphocytes; CD4-Positive T-Lymphocytes; Disease Models, Animal; Flow Cytometry; Leukocyte Count; Lymphocytes; Macrophage-1 Antigen; Mice; Mice, Inbred BALB C; Receptors, Leukocyte-Adhesion; T-Lymphocytes; Zidovudine

1990
Postexposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:3

    Topics: Animals; Chimera; Disease Models, Animal; HIV Infections; HIV-1; Mice; Mice, Inbred Strains; Time Factors; Zidovudine

1991
An animal model for the study of azidothymidine-induced hyperpigmentation.
    Laboratory investigation; a journal of technical methods and pathology, 1991, Volume: 64, Issue:3

    Topics: Animals; Disease Models, Animal; Melanins; Mice; Pigmentation Disorders; Skin; Zidovudine

1991
Zidovudine (AZT) reduces virus titer, retards immune dysfunction, and prolongs survival in the LP-BM5 murine induced immunodeficiency model.
    The Journal of infectious diseases, 1990, Volume: 161, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Animals; Cell Separation; Disease Models, Animal; Female; Flow Cytometry; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Leukemia Virus, Murine; Leukemia, Experimental; Lymph Nodes; Mice; Mice, Inbred C57BL; Organ Size; Spleen; Zidovudine

1990
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
    Journal of acquired immune deficiency syndromes, 1990, Volume: 3, Issue:5

    Topics: Animals; Antibodies, Viral; Disease Models, Animal; Friend murine leukemia virus; Genotype; HIV Infections; Killer Cells, Natural; Leukocyte Count; Macrophages; Male; Mice; Mice, Inbred Strains; Retroviridae Infections; Spleen; T-Lymphocytes; Zidovudine

1990
Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits.
    Leukemia research, 1990, Volume: 14, Issue:10

    Topics: Animals; Cell Line, Transformed; Cell Transformation, Viral; Disease Models, Animal; Human T-lymphotropic virus 1; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Polymerase Chain Reaction; Proviruses; Rabbits; Tumor Cells, Cultured; Zidovudine

1990
Feline immunodeficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Cats; Cells, Cultured; Disease Models, Animal; Humans; Retroviridae; Retroviridae Infections; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine

1989
Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
    Intervirology, 1989, Volume: 30 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; Antiviral Agents; Cats; Cell Line; Didanosine; Dideoxyadenosine; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Immunologic Deficiency Syndromes; Leukemia Virus, Feline; Leukemia, Experimental; Nucleosides; Specific Pathogen-Free Organisms; Virus Replication; Zalcitabine; Zidovudine

1989
Murine models for antiretroviral therapy.
    Intervirology, 1989, Volume: 30 Suppl 1

    Topics: Acquired Immunodeficiency Syndrome; Animals; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Interferon Type I; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Rauscher Virus; Recombinant Proteins; Retroviridae; Retroviridae Infections; Viremia; Zidovudine

1989
AIDS. Complexities and strategies.
    Nature, 1989, Oct-19, Volume: 341, Issue:6243

    Topics: Acquired Immunodeficiency Syndrome; Disease Models, Animal; Humans; Viral Vaccines; Zidovudine

1989
[AIDS also an experimental problem. Selection of experimental animals is difficult--no new therapeutic approaches in view].
    Fortschritte der Medizin, 1988, Aug-30, Volume: 106, Issue:25

    Topics: Acquired Immunodeficiency Syndrome; Animals; Disease Models, Animal; HIV; Macaca fascicularis; Zidovudine

1988